A Century of the Phage: Past, Present and Future
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phages and Human Health: More Than Idle Hitchhikers
viruses Review Phages and Human Health: More Than Idle Hitchhikers Dylan Lawrence 1,2 , Megan T. Baldridge 1,2,* and Scott A. Handley 2,3,* 1 Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA 2 Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA 3 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA * Correspondence: [email protected] (M.T.B.); [email protected] (S.A.H.) Received: 2 May 2019; Accepted: 25 June 2019; Published: 27 June 2019 Abstract: Bacteriophages, or phages, are viruses that infect bacteria and archaea. Phages have diverse morphologies and can be coded in DNA or RNA and as single or double strands with a large range of genome sizes. With the increasing use of metagenomic sequencing approaches to analyze complex samples, many studies generate massive amounts of “viral dark matter”, or sequences of viral origin unable to be classified either functionally or taxonomically. Metagenomic analysis of phages is still in its infancy, and uncovering novel phages continues to be a challenge. Work over the past two decades has begun to uncover key roles for phages in different environments, including the human gut. Recent studies in humans have identified expanded phage populations in both healthy infants and in inflammatory bowel disease patients, suggesting distinct phage activity during development and in specific disease states. In this review, we examine our current knowledge of phage biology and discuss recent efforts to improve the analysis and discovery of novel phages. -
Jewels in the Crown
Jewels in the crown CSHL’s 8 Nobel laureates Eight scientists who have worked at Cold Max Delbrück and Salvador Luria Spring Harbor Laboratory over its first 125 years have earned the ultimate Beginning in 1941, two scientists, both refugees of European honor, the Nobel Prize for Physiology fascism, began spending their summers doing research at Cold or Medicine. Some have been full- Spring Harbor. In this idyllic setting, the pair—who had full-time time faculty members; others came appointments elsewhere—explored the deep mystery of genetics to the Lab to do summer research by exploiting the simplicity of tiny viruses called bacteriophages, or a postdoctoral fellowship. Two, or phages, which infect bacteria. Max Delbrück and Salvador who performed experiments at Luria, original protagonists in what came to be called the Phage the Lab as part of the historic Group, were at the center of a movement whose members made Phage Group, later served as seminal discoveries that launched the revolutionary field of mo- Directors. lecular genetics. Their distinctive math- and physics-oriented ap- Peter Tarr proach to biology, partly a reflection of Delbrück’s physics train- ing, was propagated far and wide via the famous Phage Course that Delbrück first taught in 1945. The famous Luria-Delbrück experiment of 1943 showed that genetic mutations occur ran- domly in bacteria, not necessarily in response to selection. The pair also showed that resistance was a heritable trait in the tiny organisms. Delbrück and Luria, along with Alfred Hershey, were awarded a Nobel Prize in 1969 “for their discoveries concerning the replication mechanism and the genetic structure of viruses.” Barbara McClintock Alfred Hershey Today we know that “jumping genes”—transposable elements (TEs)—are littered everywhere, like so much Alfred Hershey first came to Cold Spring Harbor to participate in Phage Group wreckage, in the chromosomes of every organism. -
Max Ludwig Henning Delbruck (1906–1981) [1]
Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Max Ludwig Henning Delbruck (1906–1981) [1] By: Hernandez, Victoria Max Ludwig Henning Delbrück applied his knowledge of theoretical physics to biological systems such as bacterial viruses called bacteriophages, or phages, and gene replication during the twentieth century in Germany and the US. Delbrück demonstrated that bacteria undergo random genetic mutations to resist phage infections. Those findings linked bacterial genetics to the genetics of higher organisms. In the mid-twentieth century, Delbrück helped start the Phage Group and Phage Course in the US, which further organized phage research. Delbrück also contributed to the DNA replication debate that culminated in the 1958 Meselson-Stahl experiment, which demonstrated how organisms replicate their genetic information. For his work with phages, Delbrück earned part of the 1969 Nobel Prize for Physiology or Medicine. Delbrück's work helped shape and establish new fields in molecular biology and genetics to investigate the laws of inheritance and development. Delbrück was born on 4 September 1906, as the last of seven children of Lina and Hans Delbrück, in Berlin, Germany. Delbrück grew up in Grunewald, a suburb of Berlin. In 1914, World War I [2] began. During the war, Delbrück's family struggled with food shortages and in 1917 Delbrück's oldest brother died in combat. After the war ended in 1918, Delbrück began to study astronomy. Some nights, Delbrück woke up in the middle of the night to observe the stars with his telescope. He also read about the seventeenth-century astronomer Johannes Kepler, who studied planetary motion in late sixteenth and early seventeenth century Germany. -
Martha Chase Dies
PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central Martha Chase dies ArticleInfo ArticleID : 4830 ArticleDOI : 10.1186/gb-spotlight-20030820-01 ArticleCitationID : spotlight-20030820-01 ArticleSequenceNumber : 182 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 4 RegistrationDate : 2003–8–20 ArticleHistory : OnlineDate : 2003–8–20 ArticleCopyright : BioMed Central Ltd2003 ArticleGrants : ArticleContext : 130594411 Milly Dawson Email: [email protected] Martha Chase, renowned for her part in the pivotal "blender experiment," which firmly established DNA as the substance that transmits genetic information, died of pneumonia on August 8 in Lorain, Ohio. She was 75. In 1952, Chase participated in what came to be known as the Hershey-Chase experiment in her capacity as a laboratory assistant to Alfred D. Hershey. He won a Nobel Prize for his insights into the nature of viruses in 1969, along with Max Delbrück and Salvador Luria. Peter Sherwood, a spokesman for Cold Spring Harbor Laboratory, where the work took place, described the Hershey-Chase study as "one of the most simple and elegant experiments in the early days of the emerging field of molecular biology." "Her name would always be associated with that experiment, so she is some sort of monument," said her longtime friend Waclaw Szybalski, who met her when he joined Cold Spring Harbor Laboratory in 1951 and who is now a professor of oncology at the University of Wisconsin-Madison. Szybalski attended the first staff presentation of the Hershey-Chase experiment and was so impressed that he invited Chase for dinner and dancing the same evening. "I had an impression that she did not realize what an important piece of work that she did, but I think that I convinced her that evening," he said. -
UC Davis Norma J
UC Davis Norma J. Lang Prize for Undergraduate Information Research Title The Secret Life of Bacteriophages: How Did They Originate? Permalink https://escholarship.org/uc/item/0mv3j0wg Author Hand, Katherine Publication Date 2021-05-28 eScholarship.org Powered by the California Digital Library University of California Hand 1 Katherine Hand March 12, 2021 Dr. Bradley Sekedat UWP 101 The Secret Life of Bacteriophages: How Did They Originate? One of life’s greatest mysteries, the origin of viruses, remains unsolved. To crack the case, scientists proposed three major hypotheses. How the origins of viruses continue to remain undiscovered despite the hypotheses put forward calls for further investigation into the topic. Discovered in the early twentieth century by Frederick Twort and Felix d’Herelle ( Drulis-Kawa et al., 2015 ), bacteriophages are considered the most successful entities (Moelling, 2012) and they help build the genomes of all species. What began as a narrow belief that viruses only prefer to genetically exchange with hosts of their superkingdom (Archaea, Bacteria, or Eukarya), studies on bacteriophages prove this untrue. The secret life of bacteriophages is seemingly more peculiar in the human gut as they coevolve with bacteria and interact with our immune system. Their distinctive interactions with white blood cells (WBC) and their hosts demonstrate a connection with their protein fold and structural make-up. This leaves us with an interesting question: where did the phages originate from? Assessing how bacteriophages can be antimorphic mutations 1 of early bacterial defense mechanisms where an accumulation of proteins that should not have bound together, bound together over time and self-infected a bacterial cell from within might be our answer. -
Alfred Day Hershey (1908–1997) [1]
Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Alfred Day Hershey (1908–1997) [1] By: Hernandez, Victoria Keywords: Hershey, Alfred Day [2] Lambda phage [3] Bacteriophage [4] Hershey-Chase experiments [5] During the twentieth century in the United States, Alfred Day Hershey studied phages, or viruses that infect bacteria, and experimentally verified that genes [6] were made of deoxyribonucleic acid, or DNA. Genes are molecular, heritable instructions for how an organism develops. When Hershey started to study phages, scientists did not know if phages contained genes [6], or whether genes [6] were made of DNA or protein. In 1952, Hershey and his research assistant, Martha Chase, conducted phage experiments that convinced scientists that genes [6] were made of DNA. For his work with phages, Hershey shared the 1969 Nobel Prize in Physiology or Medicine [7] with Max Delbrück and Salvador Luria. Hershey conducted experiments with results that connected DNA to the function of genes [6], thereby changing the way scientists studied molecular biology and the development of organisms. Hershey was born on 4 December 1908 to Alma Wilbur and Robert Hershey in Owosso, Michigan. He attended public schools in both Owosso and Lansing, Michigan, where his father worked as a stockkeeper at an automobile factory. For his higher education, Hershey attended Michigan State College, later called Michigan State University, in East Lansing, Michigan. There, he received his Bachelor’s of Science in chemistry in 1930 and his PhD in bacteriology and chemistry in 1934. Hershey wrote his doctoral dissertation on the separation of chemical constituents, or components like sugars, fats, and proteins, from different strains of the Brucella [8] bacterial group. -
When Physics Meets Biology: a Less Known Feynman
When physics meets biology: a less known Feynman Marco Di Mauro, Salvatore Esposito, and Adele Naddeo INFN Sezione di Napoli, Naples - 80126, Italy We discuss a less known aspect of Feynman’s multifaceted scientific work, centered about his interest in molecular biology, which came out around 1959 and lasted for several years. After a quick historical reconstruction about the birth of molecular biology, we focus on Feynman’s work on genetics with Robert S. Edgar in the laboratory of Max Delbruck, which was later quoted by Francis Crick and others in relevant papers, as well as in Feynman’s lectures given at the Hughes Aircraft Company on biology, organic chemistry and microbiology, whose notes taken by the attendee John Neer are available. An intriguing perspective comes out about one of the most interesting scientists of the XX century. 1. INTRODUCTION Richard P. Feynman has been – no doubt – one of the most intriguing characters of XX century physics (Mehra 1994). As well known to any interested people, this applies not only to his work as a theoretical physicist – ranging from the path integral formulation of quantum mechanics to quantum electrodynamics (granting him the Nobel prize in Physics in 1965), and from helium superfluidity to the parton model in particle physics –, but also to his own life, a number of anecdotes being present in the literature (Mehra 1994; Gleick 1992; Brown and Rigden 1993; Sykes 1994; Gribbin and Gribbin 1997; Leighton 2000; Mlodinov 2003; Feynman 2005; Henderson 2011; Krauss 2001), including his own popular -
Phage Therapy in Veterinary Medicine
antibiotics Review Phage Therapy in Veterinary Medicine Rosa Loponte, Ugo Pagnini, Giuseppe Iovane and Giuseppe Pisanelli * Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy; [email protected] (R.L.); [email protected] (U.P.); [email protected] (G.I.) * Correspondence: [email protected]; Tel.: +39-081-2536363 Abstract: To overcome the obstacle of antimicrobial resistance, researchers are investigating the use of phage therapy as an alternative and/or supplementation to antibiotics to treat and prevent infections both in humans and in animals. In the first part of this review, we describe the unique biological characteristics of bacteriophages and the crucial aspects influencing the success of phage therapy. However, despite their efficacy and safety, there is still no specific legislation that regulates their use. In the second part of this review, we describe the comprehensive research done in the past and recent years to address the use of phage therapy for the treatment and prevention of bacterial disease affecting domestic animals as an alternative to antibiotic treatments. While in farm animals, phage therapy efficacy perspectives have been widely studied in vitro and in vivo, especially for zoonoses and diseases linked to economic losses (such as mastitis), in pets, studies are still few and rather recent. Keywords: alternative to antibiotics; bacteriophages; phage therapy; veterinary medicine; pets Citation: Loponte, R.; Pagnini, U.; 1. Introduction and History Notes Iovane, G.; Pisanelli, G. Phage Therapy in Veterinary Medicine. Bacteriophages are viruses that parasitize bacteria. This attribute can be used to treat Antibiotics 2021, 10, 421. -
Genetics and Development at the Threshold of Life—The Caltech
Genetics and Development at the Threshold of Life- By ROBERT S. EDGAR and WILLIAM B. WOOD Although bacteriophages-viruses which attack bacteria-have been known for over 60 years, the detailed study of their reproductive cycle began only in the early 1940's. At that time Max Delbriick, a former physicist and visiting research fellow at Caltech who had become interested in the mech- anism of heredity, recognized in the phage an ideal experimental material for exploring the nature of the gene. In the succeeding years, many of today's leading contributors to the field now known as mo- lecular biology passed through Dr. Delbriick's "Cal- tech Phage Group" as graduate students and post- doctoral fellows, and research with bacteriophages led directly or indirectly to much of the recent ex- plosive progress in this new science. Bacteriophages, as Delbrtick suspected, proved ideally suited to studies of the molecular basis of heredity. They represent the simplest genetic sys- tems we know-life trimmed to its barest essentials. The bacterial hosts on which they grow are them- selves simple (as cellular organisms go), generally harmless, and easy to culture and manipulate in the laboratory. Despite their extreme simplicity, how- ever, bacteriophages transmit and utilize their ge- netic information by the same basic mechanisms that are common throughout the biological world, with the consequence that phage research has been Heads, tails, and tail fibers of T4 bacteriophages can be of value in understanding not only the process of distinguished In this micrograph taken by Ronald virus multiplication but also problems of heredity Luftig. -
Bacteriophages As Potential Tools for Use in Antimicrobial Therapy and Vaccine Development
pharmaceuticals Review Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development Beata Zalewska-Pi ˛atek 1,* and Rafał Pi ˛atek 1,2 1 Department of Molecular Biotechnology and Microbiology, Chemical Faculty, Gda´nskUniversity of Technology, Narutowicza 11/12, 80-233 Gda´nsk,Poland; [email protected] 2 BioTechMed Center, Gda´nskUniversity of Technology, Narutowicza 11/12, 80-233 Gda´nsk,Poland * Correspondence: [email protected]; Tel.: +58-347-1862; Fax: +58-347-1822 Abstract: The constantly growing number of people suffering from bacterial, viral, or fungal infec- tions, parasitic diseases, and cancers prompts the search for innovative methods of disease prevention and treatment, especially based on vaccines and targeted therapy. An additional problem is the global threat to humanity resulting from the increasing resistance of bacteria to commonly used antibiotics. Conventional vaccines based on bacteria or viruses are common and are generally effective in pre- venting and controlling various infectious diseases in humans. However, there are problems with the stability of these vaccines, their transport, targeted delivery, safe use, and side effects. In this context, experimental phage therapy based on viruses replicating in bacterial cells currently offers a chance for a breakthrough in the treatment of bacterial infections. Phages are not infectious and pathogenic to eukaryotic cells and do not cause diseases in human body. Furthermore, bacterial viruses are sufficient immuno-stimulators with potential adjuvant abilities, easy to transport, and store. They can also be produced on a large scale with cost reduction. In recent years, they have also provided an ideal platform for the design and production of phage-based vaccines to induce protective host immune responses. -
Chapter 22 Max at Vanderbilt David F
Chapter 22 Max at Vanderbilt David F. Salisbury Associate Director Science & Research Communications Vanderbilt University Nashville, Tennessee Allison Price Editorial Assistant Vanderbilt Institute for Integrative Biosystems Research and Education Vanderbilt University Nashville, Tennessee Robert D. Collins Professor of Pathology Shapiro Chair in Pathology Vanderbilt University Medical Center Nashville, Tennessee John P. Wikswo Gordon A. Cain University Professor A.B. Learned Professor of Living State Physics Director, Vanderbilt Institute for Integrative Biosystems 213 Research and Education Professor of Biomedical Engineering, Molecular Physiology & Biophysics, and Physics Vanderbilt University Nashville, Tennessee [email protected] Th ere is a new bronze plaque dedicated to Nobel laureate Max Delbrück on the campus of Vanderbilt University in Nashville, Tennessee. Th is plaque, on the third fl oor of Buttrick Hall, reads: Located here was the laboratory of Max Delbrück, a member of the physics department faculty from 1940 to 1947. It was then that he and his group conducted fundamental studies that provided the foundation for modern molecular biology. Th is work led to his receiving, along with Alfred Hershey and Salvador Luria, the Nobel Prize in Physiology or Medicine in 1969 for discoveries concerning “the replication mechanism and genetic structure of viruses.” Max Delbrück had the greatest infl uence of any physicist on biology in the 20th century, but the fundamental role that Vanderbilt played in his life and career has been largely overlooked by the scientifi c community. To help rectify this oversight, John Wikswo, the Gordon A. Cain University Professor at Vanderbilt, organized a centenary Delbrück symposium on September 14, 2006, and the university had the plaque created and installed. -
A Review of Phage Therapy Against Bacterial Pathogens of Aquatic and Terrestrial Organisms
viruses Review A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms Janis Doss, Kayla Culbertson, Delilah Hahn, Joanna Camacho and Nazir Barekzi * Old Dominion University, Department of Biological Sciences, 5115 Hampton Blvd, Norfolk, VA 23529, USA; [email protected] (J.D.); [email protected] (K.C.); [email protected] (D.H.); [email protected] (J.C.) * Correspondence: [email protected] Academic Editor: Jens H. Kuhn Received: 27 January 2017; Accepted: 13 March 2017; Published: 18 March 2017 Abstract: Since the discovery of bacteriophage in the early 1900s, there have been numerous attempts to exploit their innate ability to kill bacteria. The purpose of this report is to review current findings and new developments in phage therapy with an emphasis on bacterial diseases of marine organisms, humans, and plants. The body of evidence includes data from studies investigating bacteriophage in marine and land environments as modern antimicrobial agents against harmful bacteria. The goal of this paper is to present an overview of the topic of phage therapy, the use of phage-derived protein therapy, and the hosts that bacteriophage are currently being used against, with an emphasis on the uses of bacteriophage against marine, human, animal and plant pathogens. Keywords: bacteriophage; Vibrio phage; phage therapy; aquaculture 1. Introduction Bacteriophage are commonly referred to as phage and are defined as viruses that infect bacteria. Phage are ubiquitous and require a bacterial host. They are also the most abundant organisms found in the biosphere. Bacteriophage-bacterial host interactions have been exploited by scientists as tools to understand basic molecular biology, genetic recombination events, horizontal gene transfer, and how bacterial evolution has been driven by phage [1].